FDA commissioner Hahn ousts agency’s new chief spokesperson as plasma controversy continues to smolder
FDA commissioner Stephen Hahn capped a week of controversy over a fiasco revolving around his misleading comments on a Covid-19 treatment by ousting the agency’s newly-hired chief spokesperson, Emily Miller.
Miller had worked at the right-wing cable news network One America News — a favorite of President Trump’s — as well as for the campaign of Senator Ted Cruz before she was placed at the FDA just 11 days ago, according to the New York Times, which broke the story. Her appointment raised eyebrows at an agency that has long hired civil servants for such positions and worked to maintain its independence from political winds.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 112,600+ biopharma pros reading Endpoints daily — and it's free.